Filing Details
- Accession Number:
- 0001209191-15-079802
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-11-12 17:43:22
- Reporting Period:
- 2015-11-11
- Filing Date:
- 2015-11-12
- Accepted Time:
- 2015-11-12 17:43:22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1469443 | Arcadia Biosciences Inc. | RKDA | Agricultural Chemicals (2870) | 810571538 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1640658 | C. Vic Knauf | C/O Arcadia Biosciences, Inc. 202 Cousteau Place, Suite 105 Davis CA 95618 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-11-11 | 20,000 | $0.44 | 51,661 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-11-11 | 4,527 | $2.91 | 47,134 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2015-11-11 | 20,000 | $0.00 | 20,000 | $0.44 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2015-12-31 | No | 4 | M | Direct |
Footnotes
- The security transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Stock Trading Plan (the "Plan"), adopted by the Reporting Person effective June 12, 2015.
- This transaction was executed in multiple trades at prices ranging from $2.82 to $2.9224. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The option is fully exercisable as of the date hereof.